Table 2.
Timing of rituximab administration | Number of patients who suffered from infusion reactions | Number of patients who had no infusion reactions | Total number of patients |
---|---|---|---|
With the first course of chemotherapy |
14 |
15 |
29 |
With or after the second course of chemotherapy | 4 | 23 | 27 |